[go: up one dir, main page]

MX2019013161A - Inmunoterapia personalizada contra diversos tumores cerebrales y neuronales. - Google Patents

Inmunoterapia personalizada contra diversos tumores cerebrales y neuronales.

Info

Publication number
MX2019013161A
MX2019013161A MX2019013161A MX2019013161A MX2019013161A MX 2019013161 A MX2019013161 A MX 2019013161A MX 2019013161 A MX2019013161 A MX 2019013161A MX 2019013161 A MX2019013161 A MX 2019013161A MX 2019013161 A MX2019013161 A MX 2019013161A
Authority
MX
Mexico
Prior art keywords
present
tumor
relates
brain tumors
against several
Prior art date
Application number
MX2019013161A
Other languages
English (en)
Inventor
Weinschenk Toni
fritsche Jens
Walter Steffen
Singh Harpreet
Song Colette
Hilf Norbert
Schorr Oliver
KUTTRUFF-COQUI Sabrina
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1319446.9A external-priority patent/GB201319446D0/en
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of MX2019013161A publication Critical patent/MX2019013161A/es

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a péptidos, ácidos nucleicos y células destinados a la utilización en métodos inmunoterapéuticos. En particular, la presente invención se refiere a la inmunoterapia contra el cáncer. La presente invención se refiere asimismo a epítopos peptídicos para linfocitos T citotóxicos (CTL) asociados a tumores, solos o en combinación con otros péptidos asociados a tumores que pueden servir como principios activos farmacéuticos en composiciones vacunales destinadas a estimular respuestas inmunitarias antitumorales. La presente invención se refiere específicamente a secuencias peptídicas y sus variantes derivadas de moléculas HLA de clase I y clase II de células tumorales humanas que pueden ser utilizadas en composiciones vacunales para desencadenar respuestas inmunitarias antitumorales.
MX2019013161A 2013-11-04 2016-05-04 Inmunoterapia personalizada contra diversos tumores cerebrales y neuronales. MX2019013161A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361899680P 2013-11-04 2013-11-04
GBGB1319446.9A GB201319446D0 (en) 2013-11-04 2013-11-04 Personalized immunotherapy against several neuronal and brain tumors

Publications (1)

Publication Number Publication Date
MX2019013161A true MX2019013161A (es) 2020-02-03

Family

ID=70386385

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019013161A MX2019013161A (es) 2013-11-04 2016-05-04 Inmunoterapia personalizada contra diversos tumores cerebrales y neuronales.

Country Status (2)

Country Link
JP (1) JP6963836B2 (es)
MX (1) MX2019013161A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118615445A (zh) * 2023-03-09 2024-09-10 中国医学科学院肿瘤医院 Tnc高表达在食管鳞癌诊断和治疗中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2562184T3 (pl) * 2007-07-27 2016-03-31 Immatics Biotechnologies Gmbh Nowe immunogenne epitopy do immunoterapii
DK2172211T3 (en) * 2008-10-01 2015-02-16 Immatics Biotechnologies Gmbh Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
GB201319446D0 (en) * 2013-11-04 2013-12-18 Immatics Biotechnologies Gmbh Personalized immunotherapy against several neuronal and brain tumors

Also Published As

Publication number Publication date
JP2020062025A (ja) 2020-04-23
JP6963836B2 (ja) 2021-11-10

Similar Documents

Publication Publication Date Title
SG10201900727QA (en) Personalized immunotherapy against several neuronal and brain tumors
PH12021551208A1 (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
PH12015502638A1 (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MX2016014711A (es) Inmunoterapia novedosa contra varios tumores de la sangre, con la leucemia mielogena aguda (lma).
PH12019502194A1 (en) Novel immunotherapy against several tumors including gastrointestinal and gastric cancer
WO2015193359A3 (en) Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (cll)
MX338294B (es) Novedoso inmunotratamiento contra diversos tumores incluidos tumores neuronales y cerebrales.
PH12016502008A1 (en) Novel immunotherapy against several tumors of the blood, such as acute myeloid lukemia (aml)
MX2019013161A (es) Inmunoterapia personalizada contra diversos tumores cerebrales y neuronales.
MY193910A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MY194241A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including NSCLC
MY194244A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc
MY194653A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
EA201990696A1 (ru) Персонализированная иммунотерапия нескольких видов нейрональных опухолей и опухолей головного мозга
EA202090816A2 (ru) Новый метод иммунотерапии нескольких видов опухолей, таких как рак легкого, включая нмрл
MY198397A (en) Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer